Skip to main content
. 2016 Apr 16;16:18. doi: 10.1186/s12894-016-0136-8

Table 1.

Study design for ProSCIUTTU

LGG -BB12 (B) Active (186) LGG -BB12 (b) Placebo (186)
GR1-RC14 (A) Active (186) AB or Intervention A (93) Ab or Intervention B (93)
GR1-RC14 (a) Placebo (186) aB or Intervention C (93) ab or Intervention D (93)